SCHEMBL29148559

SCHEMBL29148559

COC(=O)c1cc(OC(F)C(F)F)nn1C

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA12 O43570 1/20 0.37
▸ CA1 P00915 1/20 0.37
▸ CA2 P00918 1/20 0.37
▸ CA9 Q16790 1/20 0.37
▸ SMN1; SMN2 Q16637 5/20 0.34
▸ NPC1 O15118 4/20 0.34
▸ RAB9A P51151 4/20 0.34
▸ ALDH1A1 P00352 8/20 0.34
▸ KDM4E B2RXH2 7/20 0.34
▸ HPGD P15428 3/20 0.34
▸ PKM P14618 2/20 0.34
▸ HSD17B10 Q99714 2/20 0.33
▸ GAA P10253 1/20 0.33
▸ ALOX15 P16050 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ CYP1A2 P05177 2/20 0.32
▸ CYP3A4 P08684 2/20 0.32
▸ CYP2C9 P11712 2/20 0.32
▸ CYP2C19 P33261 2/20 0.32
▸ LMNA P02545 3/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2362608 0.88 CA12 (0.38) CA12CA1CA2CA9SMN1; SMN2
SCHEMBL29148604 0.85 KDM4E (0.45) CA12CA1CA2CA9NPC1
SCHEMBL2512844 0.79 ALDH1A1 (0.47) CA12CA1CA2CA9SMN1; SMN2
SCHEMBL21597813 0.76 PKM (0.41) CA12CA1CA2CA9SMN1; SMN2
SCHEMBL19556332 0.75 CA12 (0.40) CA12CA1CA2CA9SMN1; SMN2
SCHEMBL25348892 0.75 PKM (0.40) CA12CA1CA2CA9SMN1; SMN2
SCHEMBL2516485 0.74 CA12 (0.44) CA12CA1CA2CA9SMN1; SMN2
SCHEMBL17473324 0.74 CA12 (0.41) CA12CA1CA2CA9SMN1; SMN2
SCHEMBL21597836 0.73 CA12 (0.39) CA12CA1CA2CA9SMN1; SMN2
SCHEMBL20319776 0.73 CA12 (0.39) CA12CA1CA2CA9SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117136052-A CDK inhibitors and methods of use thereof 传达治疗有限公司 2023-11-28 — — CN disclosed
Send feedback